5 Shocking Ways Kelly Osbourne’s Stance On Ozempic Has Drastically Changed

Contents
Kelly Osbourne’s weight loss journey has been a public and often controversial topic for over a decade, but the conversation reached a fever pitch in late 2024 and early 2025 with persistent rumors linking her transformation to the diabetes-turned-weight-loss drug, Ozempic. The reality star, known for her candid nature, initially and vehemently denied using the medication, attributing her dramatic 85-pound weight loss to bariatric surgery and a commitment to sobriety. However, recent, fresh updates from *The Osbournes Podcast* reveal a significant and surprising evolution in her public stance, moving from a firm denial to openly endorsing the drug as a viable option for those struggling with obesity. As of December 2025, the narrative surrounding Kelly Osbourne and Ozempic is no longer about whether she used it for her initial weight loss—which she continues to deny—but about her current, vocal support for the medication, placing her firmly in the middle of Hollywood's most polarizing health debate. This article delves into the timeline of her transformation, the initial denial, the role of her mother Sharon Osbourne's negative experience, and the five key takeaways from Kelly’s drastically changed perspective on the popular GLP-1 receptor agonist.

Kelly Osbourne: A Snapshot Biography & Career Milestones

Kelly Michelle Lee Osbourne is a British media personality, singer, actress, and fashion designer who first gained worldwide recognition through her family's reality show. Her life, marked by both professional success and personal struggles with addiction and weight, has been continually under the public microscope.

  • Full Name: Kelly Michelle Lee Osbourne
  • Date of Birth: October 27, 1984
  • Current Age (as of 2025): 41
  • Parents: Ozzy Osbourne (father) and Sharon Osbourne (mother)
  • Net Worth: Estimated at $16 million (2025)
  • Key Career Highlights:
    • Reality TV Star on The Osbournes (2002–2005)
    • Pop/Rock Singer (Debut album Shut Up in 2002)
    • Host/Panelist on Fashion Police (2010–2015)
    • Contestant on Dancing with the Stars (Season 9)
    • Author of the memoir There Is No F*cking Secret: Letters From a Bipolar Princess

The 85-Pound Transformation: Gastric Sleeve vs. The Ozempic Rumor Mill

The foundation of Kelly Osbourne’s dramatic physical change lies in a multi-year commitment to health, which began long before the Ozempic craze swept Hollywood. Her journey is a testament to overcoming personal obstacles, but the public often seeks a simpler explanation.

The Reality: Gastric Sleeve and Sobriety

In 2020, Kelly Osbourne revealed that she had undergone a gastric sleeve surgery, a type of bariatric surgery, two years prior. This procedure, which permanently removes a portion of the stomach, significantly restricts food intake and is a major medical intervention for weight management. She has consistently stated that the surgery, combined with a dedicated focus on sobriety and sustained diet and exercise, was responsible for her 85-pound weight loss.

In a 2024 interview, Kelly directly addressed the Ozempic speculation, asserting, “I know everybody thinks I took Ozempic. I did not take Ozempic.” She has often expressed frustration with the persistent rumors, feeling they diminish the hard work and life changes she made following her surgery and her commitment to a sober lifestyle.

The Persistent Ozempic Accusations

Despite her explicit denials, the intensity of the Ozempic (semaglutide) trend in Hollywood meant that any significant, rapid celebrity weight loss was immediately linked to the drug. Trolls and critics frequently accused her of lying about her method, leading to public outbursts and defenses from Kelly, who maintained that her transformation was surgical and lifestyle-based.

The situation was further complicated by her mother, Sharon Osbourne, who was open about her own use of the medication. Sharon, however, shared a negative experience, detailing severe side effects like nausea and vomiting, and expressed regret over how quickly she lost weight, calling it "too much." This family dynamic created a mixed message in the media: a daughter denying use while a mother admitted to it, but with a cautionary tale.

From Skeptic to 'Fan': Kelly Osbourne's Evolving Stance on GLP-1 Drugs

The most recent and significant development in the "Kelly Osbourne Ozempic" story is the dramatic shift in her public commentary. On a recent episode of *The Osbournes Podcast*, Kelly revealed a new perspective that moves beyond her personal denial and into a broader endorsement of the medication.

5 Ways Kelly Osbourne’s View Has Changed

Kelly's evolving opinion reflects a growing acceptance of GLP-1 receptor agonists like Ozempic and Wegovy as legitimate medical tools, even for those who are not diabetic. This is a crucial pivot from her previous position, which focused solely on her own non-use.

  1. Endorsing its Use for Weight Loss: Kelly has publicly stated that she is now a "fan" of Ozempic. This is a major departure from her previous stance, where she only discussed its use in the context of her mother's journey or to deny her own involvement.
  2. Viewing it as a Medical Necessity: She now advocates for the drug as a powerful tool for people who genuinely struggle with obesity. By framing it as an option for those who have exhausted traditional methods, she legitimizes its use beyond the "Hollywood quick fix" stereotype.
  3. Addressing the Stigma: Kelly has spoken out against the judgment surrounding the use of Ozempic. Her shift in opinion seems aimed at reducing the shame associated with people seeking medical intervention for weight management, whether through bariatric surgery or medication.
  4. Separating Personal Use from General Support: While she still denies using Ozempic for her 85-pound loss—which she credits to her 2018 gastric sleeve—her new position allows her to support the drug's role in the wider health community. She is no longer just defending herself, but defending the medication itself.
  5. Highlighting the Difficulty of Weight Management: Her support acknowledges the complex, often lifelong battle with weight. By embracing the discussion around semaglutide, she highlights that even after major interventions like gastric sleeve surgery, maintaining weight loss is a continuous struggle that may require additional support.

Navigating the Celebrity Weight Loss Conversation

The dialogue around Kelly Osbourne’s weight loss is a microcosm of a much larger, global conversation about body image, medical ethics, and the influence of celebrity culture. The entities involved—Ozempic, Wegovy, bariatric surgery, and the pressure of the entertainment industry—create a complex web of topical authority.

The *Ozempic craze* has forced many public figures to either deny or defend their transformations. Kelly's journey uniquely bridges two major weight loss interventions: the permanent, surgical solution of the gastric sleeve and the pharmacological solution of the GLP-1 agonist. Her initial denial was a defense of her surgical effort, but her current endorsement reflects a broader societal shift toward accepting medical assistance for obesity.

The conversation is further nuanced by the need for these medications in the diabetic community. The off-label use of Ozempic (originally for Type 2 diabetes) for cosmetic weight loss has raised ethical concerns about drug shortages and accessibility for those who need it for chronic illness management. Kelly Osbourne’s platform, especially through *The Osbournes Podcast*, gives her a powerful voice to shape public perception, whether she is discussing her previous struggles with addiction or her current views on medical weight loss solutions.

Conclusion: Kelly Osbourne’s New Chapter on Health and Honesty

Kelly Osbourne’s journey from a reality TV rebel to a mother and health advocate has been anything but linear. Her weight loss success is rooted in major life changes, including bariatric surgery and sobriety, a fact she continues to champion. However, her recent, dramatic shift to becoming a "fan" of Ozempic marks a new chapter in her public health narrative.

This evolving stance on semaglutide is a powerful indicator of how quickly public opinion—even among high-profile celebrities—is adapting to the new reality of pharmacological weight management. Kelly Osbourne is no longer just denying a rumor; she is actively shaping the discussion, challenging the stigma, and legitimizing a controversial drug for millions who struggle with weight. Her willingness to change her mind, even in the face of her mother's negative experience, makes her voice one of the most compelling and current in the celebrity weight loss debate of 2025.

kelly osbourne ozempic
kelly osbourne ozempic

Detail Author:

  • Name : Eldon Larson PhD
  • Username : danny.swift
  • Email : qmaggio@hotmail.com
  • Birthdate : 2002-05-08
  • Address : 324 Aaliyah Roads Apt. 170 Port Wernerberg, CT 71594
  • Phone : 469-431-0635
  • Company : Hayes-Feeney
  • Job : Woodworking Machine Setter
  • Bio : Ut qui pariatur autem. Earum aut adipisci quia placeat. Id reprehenderit aut dolorem quis molestias neque est corrupti. Ullam adipisci dolore consequatur.

Socials

facebook:

  • url : https://facebook.com/howella
  • username : howella
  • bio : Et molestiae non mollitia et. Sequi beatae ad voluptate est et ea.
  • followers : 1280
  • following : 2833

twitter:

  • url : https://twitter.com/amalia_howell
  • username : amalia_howell
  • bio : Nisi ad velit quod autem et. Quos et aspernatur maiores repellendus facilis. Ut ab dolor magnam odit animi.
  • followers : 3321
  • following : 1145

instagram:

  • url : https://instagram.com/howella
  • username : howella
  • bio : Perspiciatis non est ut eligendi quis perferendis. Adipisci nemo inventore autem tempore.
  • followers : 2806
  • following : 1778

linkedin: